Husseini Manji, M.D.
Husseini K. Manji, M.D., FRCPC, is Visiting Professor, Oxford University and Duke University, and former Global Therapeutic Head for Neuroscience at Janssen Research & Development, LLC, one of the Johnson & Johnson pharmaceutical companies. Manji was previously chief of the Laboratory of Molecular Pathophysiology & Experimental Therapeutics at the National Institute of Mental Health (NIMH) and director of the National Institutes of Health’s (NIH) Mood and Anxiety Disorders Program. He has been inducted into the National Academy of Medicine and is a member of the NIH Novel and Exceptional Technology and Research Advisory Committee, the World Dementia Council, the World Economic Forum Global Future Councils, the board of Mass General-Brigham, Incorporated, the board of trustees of Harvard University/McLean Hospital, and the scientific advisory board of the Stanley Center at the Broad Institute of MIT and Harvard. He is chair of the National Academy of Medicine Neuroscience, Behavior, Brain Function & Disorders group, co-chair of the Healthy Brains Global Initiative, and has held numerous leadership positions within the NIH, NAM, the FNIH Biomarkers Consortium Executive Committee.
Manji has received numerous awards, including the NIMH Director’s Career Award for Significant Scientific Achievement, PhRMA Research & Hope Award for Excellence in Biopharmaceutical Research, the American Federation for Aging Research Award of Distinction, the A.E. Bennett Award for Neuropsychiatric Research, the Ziskind-Somerfeld Award for Neuropsychiatric Research, the NARSAD Mood Disorders Prize, the Caring Kind Alzheimer’s Disease Leadership Award, and the Global Health & the Arts Award of Recognition, among others. He has been recognized as 1 of 14 inaugural “Health Heroes” by O, The Oprah Magazine and published over 350 articles on the neurobiology of severe neuropsychiatric and neurodegenerative disorders and the development of novel therapeutics.